Is it Time to Dump Evoke Pharma Inc (EVOK) Stock After it Has Risen 7.33% in a Week?

Evoke Pharma Inc (EVOK) stock has gained 7.33% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Evoke Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EVOK!

See Full EVOK Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With EVOK Stock Today?

Evoke Pharma Inc (EVOK) stock is lower by -0.62% while the S&P 500 is up 0.59% as of 11:46 AM on Tuesday, Jun 13. EVOK has fallen -$0.01 from the previous closing price of $1.62 on volume of 427,612 shares. Over the past year the S&P 500 has gained 16.40% while EVOK has fallen -22.97%. EVOK lost -$2.52 per share in the over the last 12 months. To screen for more stocks like Evoke Pharma Inc click here.

More About Evoke Pharma Inc

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. Click Here to get the full Stock Report for Evoke Pharma Inc stock.